Varian’s Cancer Treatment System Receives Chinese Approval
November 29, 2018
Varian’s Halcyon system has been given the go-ahead from the China National Medical Product Administration (NMPA), allowing the company to market the cancer treatment system.
The device has already received approvals in the U.S., EU, Japan, India and Brazil.
The image-guided radiotherapy offers advanced treatments for lung, breast, prostate, head, neck and other forms of cancer. It also offers improved tissue visualization using kilo-voltage cone beam computed tomography.